Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
03/31/2004 | EP1037865A4 Synthesis of cc-1065/duocarmycin analogs |
03/31/2004 | EP0865417B1 Improved hydrogenolysis of 2,4,6,8,10,12-hexabenzyl-2,4,6,8,10,12-hexaazatetracyclo 5.5.0.0?5,9 .0?3,11 ]dodecane |
03/31/2004 | CN1486319A Synthesis of temozolomide and analogs |
03/31/2004 | CN1486318A Improved process for carbapenem synthesis |
03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |
03/31/2004 | CN1486311A Pyrazole compounds useful as protein kinase inhibitors |
03/31/2004 | CN1486310A Pyrazole compounds useful as protein kinase inhibitors |
03/31/2004 | CN1486205A Use of flumazenil in developing a drug for the treatment of alcohol dependence |
03/31/2004 | CN1486184A Lactam compound to inhibit beta-amyloid peptide release or synthesis |
03/31/2004 | CN1485327A Tiemomium azoleamine-8-carboxylic acid ester and 8-amide derivatives,its synthesizing method and application in producing anticancer preparation |
03/30/2004 | US6713634 Pyrroloazepine derivatives |
03/30/2004 | US6713633 Compounds capable of cleaving double-stranded DNA and method of utilization of the same |
03/30/2004 | US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
03/30/2004 | US6713484 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
03/30/2004 | US6713483 [1,2,3]-triazolo[4,5-d] pyrimidine compounds |
03/30/2004 | US6713474 Pyrrolopyrimidines as therapeutic agents |
03/30/2004 | US6713471 Such as tert-butyl-1-methyl-6,7,9,12-tetrahydro-5h-pyrido-(4,3-b)(1,4) thiazepino(2,3,4-hi)indole-11(10h)-carboxylate; serotonin agonists and antagonists; central nervous system disorders |
03/30/2004 | US6712972 Method for the synthesis and evaluation of porphyrins, calix (4) pyrroles and allied macrocycles |
03/30/2004 | CA2091058C Methylen-oxindole derivatives and process for their preparation |
03/25/2004 | WO2004024729A1 Diazabicyclic compounds useful in the treatment of cns and other disorders |
03/25/2004 | WO2004024720A1 Piperazine urea derivatives as melanocortin-4 receptor agonists |
03/25/2004 | WO2004024702A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
03/25/2004 | WO2004024091A2 Expanded porphyrin compositions for tumor inhibition |
03/25/2004 | WO2004024078A2 Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors |
03/25/2004 | WO2003104207A3 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
03/25/2004 | WO2003086306B1 5ht2c receptor modulators |
03/25/2004 | WO2003084926A3 Polymeric acyl derivatives of indoles |
03/25/2004 | WO2003077949A3 Methods of treating diabetes using pde 11a inhibitors |
03/25/2004 | US20040059114 Intermediates useful for preparing 4,6-diaminopyrido[5,4-d]pyrimidines |
03/25/2004 | US20040058995 Agent for improving bone metabolism |
03/25/2004 | US20040058970 Alzheimer's disease |
03/25/2004 | US20040058944 Osteoporosis; antiarthritic agents; antidiabetic agents |
03/25/2004 | US20040058941 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
03/25/2004 | US20040058938 Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds |
03/25/2004 | US20040058937 Heterocyclic mutilin esters and their use as antibacterials |
03/25/2004 | US20040058933 Aryl carbamate derivatives, preperation and use thereof |
03/25/2004 | US20040058922 Tyrosine inhibitor; immunosuppressants; antiarthritic agents; autoimmune diseases; antiproliferative agent |
03/25/2004 | US20040058906 Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders |
03/25/2004 | US20040058902 Substituted porphyrins |
03/25/2004 | CA2498272A1 Piperazine urea derivatives as melanocortin-4 receptor agonists |
03/25/2004 | CA2498111A1 Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors |
03/25/2004 | CA2496563A1 New carboxamide compounds having mch-antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture |
03/24/2004 | EP1400522A1 New compounds for treating impotence |
03/24/2004 | EP1400496A1 Pigment precursors for making pigmented vitreous material |
03/24/2004 | EP1399514A2 Fluorescent diketopyrrolopyrroles |
03/24/2004 | EP1399448A1 Imidazo 1,5-a] pyrimido 5,4-d] benzazepine derivatives as gaba a receptor modulators |
03/24/2004 | EP1399447A1 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases |
03/24/2004 | EP1399444A2 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
03/24/2004 | EP1399439A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
03/24/2004 | EP1399436A2 Oxytocin agonists |
03/24/2004 | EP1399433A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
03/24/2004 | EP1303517B1 Indoloquinazolinones |
03/24/2004 | EP1252164B1 Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
03/24/2004 | EP1047690B1 Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission |
03/24/2004 | EP1024141B1 Method for acylating hexakis (arylmethyl) hexaazaisowurtzitane |
03/24/2004 | CN1484679A Acid pigment dispersamts and pigment preparations |
03/24/2004 | CN1484640A Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
03/24/2004 | CN1142934C Metallocorrinoids as biologically compatible carriers of pharmocological agents |
03/24/2004 | CN1142933C Heterocycilc compounds for inhibition of gastric acid secretion, processes for their prepn. and pharmaceutical composition thereof |
03/24/2004 | CN1142918C Carboxylic acid derivs, their preparation and their use |
03/24/2004 | CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
03/23/2004 | US6710064 Hydantoin compounds useful as anti-inflammatory agents |
03/18/2004 | WO2004022563A1 Benzotriazabicyclic derivatives and use thereof as beta-lactamase inhibitors and anti-bacterial agents |
03/18/2004 | WO2004022562A1 6-ARYL-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF |
03/18/2004 | WO2004022561A1 Pyrazolopyrimidines as cyclin-dependent kinase inhibitors |
03/18/2004 | WO2004022560A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
03/18/2004 | WO2004022559A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
03/18/2004 | WO2004022556A1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist |
03/18/2004 | WO2004022554A1 Quinazolinone derivatives |
03/18/2004 | WO2004022062A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
03/18/2004 | WO2004022054A1 Pyrazolopyridines and methods of making and using the same |
03/18/2004 | WO2004021989A2 Imidazolopyridines and methods of making and using the same |
03/18/2004 | WO2004021984A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
03/18/2004 | WO2004021979A2 PYRROLO[2, 3-d]PYRIMIDINE-4-YL AND PURIN-6-YL UREA COMPOUNDS |
03/18/2004 | WO2004010512A9 Heteroatom-containing diamondoid transistors |
03/18/2004 | WO2004009596A3 Pyrazolopyrimidines as kinase inhibitors |
03/18/2004 | WO2004006355A3 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
03/18/2004 | WO2003097608A3 Opioid and opioid-like compounds and uses thereof |
03/18/2004 | WO2003090744A8 Antibacterial compositions comprising metal phthalocyanine analogues |
03/18/2004 | WO2003070731A3 Azabicyclic compounds for the treatment of disease |
03/18/2004 | WO2003011222A3 Thrombin inhibitors |
03/18/2004 | US20040054191 Method for the continuous production of acetylene diurea |
03/18/2004 | US20040054187 Therapeutic ureas |
03/18/2004 | US20040054179 Antiallergens; skin disorders; antitumor agents; tyrosine kinase inhibitor |
03/18/2004 | US20040054177 Novel benzimidazole derivatives |
03/18/2004 | US20040054173 Antiinflammatory agents; autoimmune disease; antiarthritic agents |
03/18/2004 | US20040054170 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
03/18/2004 | US20040053986 3,7-Diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias |
03/18/2004 | US20040053955 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
03/18/2004 | US20040053947 Pyrrolo[2,3-D]pyrimidine compounds |
03/18/2004 | US20040053945 Process for the preparation of a pyrazolo[4,3-d]pyrimidine derivative |
03/18/2004 | US20040053944 Antiprotozoa agents; 4-pyrrolidine pyrrolo(3,2-d)pyrimidine and 4-pyrrolidine pyrazolo(4,3-d)pyrimidine derivatives |
03/18/2004 | US20040053931 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
03/18/2004 | US20040053924 Reacting pyrrolo(2,3-d)pyrimidin-4-one derivative containing a leaving group with a aromatic or heteroaromatic amine, hydroxy, marcaptan etc. in presence of a polar solvent and a catalyst |
03/18/2004 | US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
03/18/2004 | US20040053331 Beta-strand mimetics and method relating thereto |
03/18/2004 | CA2497970A1 Pyrazolopyridines and methods of making and using the same |
03/18/2004 | CA2497968A1 Imidazolopyridines and methods of making and using the same |
03/17/2004 | EP1398315A1 Anti-inflammatory oxo-derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use |
03/17/2004 | EP1397365A1 Novel heteroaryl-diazabicyclo-alkanes as cns-modulators |